Cardiovascular risk factors in the urban Mexican population: The FRIMEX study
Por:
Meaney E., Lara-Esqueda A., Ceballos-Reyes G.M., Asbun J., Vela A., Martínez-Marroquín Y., López V., Meaney A., de la Cabada-Tamez E., Velázquez-Monroy O., Tapia-Conyer R.
Publicada:
1 ene 2007
Categoría:
Public Health, Environmental and Occupational Health
Resumen:
Background: Atherosclerotic ischaemic heart disease is the second leading cause of general mortality in Mexico due to the growing prevalence of atherosclerotic risk factors in our society. The data of the FRIMEX study (Factores de Riesgo en México, Risk Factors in Mexico), considered together with those of other contemporary epidemiological surveys, will aid in our comprehension of the current state of cardiovascular epidemics in Mexico. Methods: Frequencies of obesity, hypertension and smoking, and total cholesterol and glucose in capillary blood were estimated in a non-probabilistic sample comprised of 140 017 individuals (aged 44±13 years; 42% men and 58% women), from six Mexican cities (Mexico City, Guadalajara, Monterrey, Puebla, Leon and Tijuana). Results: Obesity or overweight status was found in 71.9% of participants. Hypertension was found in 26.5%, and the proportions of awareness, treatment and control for this disease were 49.3, 73 and 36%, respectively. Prevalence of hypertension increased with age; while it was higher in men under 60 years of age, in the more aged individuals it was higher in women. Hypercholesterolaemia was found in 40% of the individuals and cholesterolaemia =240 mg/dl was significantly higher in women. Thirty-five and a half percent of men and 18.1% of women were smokers. Type 2 diabetes mellitus was found in 10.4% of participants. There was significant Pearson's correlation between body mass index and blood pressure, between hypertension and glucose levels, and between hypertension and total cholesterol concentrations. Conclusions: We conclude that this population has a high cardiovascular risk profile and a high probability of the occurrence of metabolic syndrome. © 2006 The Royal Institute of Public Health.
Filiaciones:
Meaney E.:
Cardiovascular Unit, Hospital Regional 1 de Octubre, ISSSTE, Ave. Politécnico 1669, Mexico City D.F. 07300, Mexico
Lara-Esqueda A.:
National Epidemiologic Surveillance Center, Adult and Aged Adult Health Program, Secretariat of Health, Mexico City, Mexico
Ceballos-Reyes G.M.:
Postgraduate and Research Division, Superior School of Medicine, National Polytechnic Institute, Mexico City, Mexico
Asbun J.:
Postgraduate and Research Division, Superior School of Medicine, National Polytechnic Institute, Mexico City, Mexico
Vela A.:
Cardiovascular Unit, Hospital Regional 1 de Octubre, ISSSTE, Ave. Politécnico 1669, Mexico City D.F. 07300, Mexico
Martínez-Marroquín Y.:
National Epidemiologic Surveillance Center, Adult and Aged Adult Health Program, Secretariat of Health, Mexico City, Mexico
López V.:
Cardiovascular Unit, Hospital Regional 1 de Octubre, ISSSTE, Ave. Politécnico 1669, Mexico City D.F. 07300, Mexico
Meaney A.:
Cardiovascular Unit, Hospital Regional 1 de Octubre, ISSSTE, Ave. Politécnico 1669, Mexico City D.F. 07300, Mexico
de la Cabada-Tamez E.:
National Epidemiologic Surveillance Center, Adult and Aged Adult Health Program, Secretariat of Health, Mexico City, Mexico
Velázquez-Monroy O.:
National Epidemiologic Surveillance Center, Adult and Aged Adult Health Program, Secretariat of Health, Mexico City, Mexico
Tapia-Conyer R.:
Undersecretariat of Prevention and Health Protection, Secretariat of Health, Mexico City, Mexico
|